Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Latest featured startups
Archon Biosciences is a biotech company pioneering computationally designed ‘Antibody Cages’ to unlock powerful therapeutic targets beyond the reach of existing modalities. Archon directly applies generative protein design to rapidly manufacture Antibody Cages (AbCs), a new class of biologics with unique potency and differentiated biodistribution. AbCs integrate the binding affinity and specificity of antibodies into […]
Founded in 2023, Cytospire Therapeutics is developing a portfolio of next-generation immune cell engagers for treating cancer. The company’s multispecific antibodies are designed to harness and direct the power of both innate and adaptive immune systems, providing a safer and more precise alternative to conventional CD3-based therapies. This is made possible by targeting a unique […]
The biotech sector continues to see a strong flow of new venture capital deals, with a flurry of new announcements this week. We saw a diverse set of companies—ranging from AI-driven drug discovery startups to firms advancing radiotherapeutic and oligonucleotide technologies—garner significant investments. Here’s a roundup of the key deals that showcase the current innovation […]